Abstract: SA-PO309

Kidney-Resident Macrophages (KRM) Upregulate Pro-Angiogenic Response in Chronic Ischemic Kidney Injury

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 308 CKD: Mechanisms of Tubulointerstitial Fibrosis


  • Puranik, Amrutesh, Mayo Clinic, Rochester, Minnesota, United States
  • Leaf, Irina Alexandra, Biogen, Cambridge, Massachusetts, United States
  • Saad, Ahmed, Mayo Clinic, Rochester, Minnesota, United States
  • Grande, Joseph P., Mayo Clinic, Rochester, Minnesota, United States
  • Textor, Stephen C., Mayo Clinic, Rochester, Minnesota, United States
  • Lerman, Amir, Mayo Clinic, Rochester, Minnesota, United States
  • Duffield, Jeremy Stuart, Vertex Pharmaceuticals, Boston, Massachusetts, United States
  • Lerman, Lilach O., Mayo Clinic, Rochester, Minnesota, United States

Macrophages (Mφ) play important roles in regulating progression & resolution of renal injury in renal artery stenosis (RAS). We have recently found that murine kidney Mφ expressing CD64+F4/80+FCRIV+CD11bintCD11cint are anti-fibrotic and reparative. We hypothesized that these are KRM & expand in mouse and human renal ischemic disease


Using CX3CR1creER:Rosa26tdTomato mice we fate-mapped the KRM and studied their kinetics in RAS. To dissect molecular mechanisms potentially underlying their protective properties in RAS, we compared KRM transcriptional profiles to non-KRM Mφ by RNA Sequencing (Fig A). Furthermore, we identified CD11bintCD11cintCD68+ KRM in human kidney biopsies of normal and RAS patient kidneys and correlated their number with kidney function (Fig B).


Fate-mapping studies identified CD64+F4/80+CD11bintCD11cint as KRM. BrdU labeling show KRM expand in RAS. KRM showed a more robust response to RAS compared to Sham KRM and non-KRM Mφ (Fig A). RAS KRM were transcriptionally heterogeneous, containing both pro- and anti-inflammatory pathways. Angiogenic Pathway was the greatest functionally enriched in RAS-KRM. Further, while both KRM and non-KRM upregulated immune pathways, only KRM downregulated immune genes including Irf5, a molecular switch to pro-inflammatory states. Finally, KRM number significantly (Fig C) increased in human stenotic kidney biopsies compared to normal and correlated with better kidney function and lower fibrosis (Fig D).


Thus, murine CD64+F4/80+FCRIV+CD11bintCD11cint Mφ are KRM, and can also be identified in human kidneys. KRM show a more robust response to chronic ischemic kidney injury compared to non-KRM Mφ, upregulating a pro-angiogenic and reparative gene profile. These observations may have important prognostic and therapeutic implications in chronic kidney injury.


  • NIDDK Support